Rhynchophylline and Alzheimer-Disease

Rhynchophylline has been researched along with Alzheimer-Disease* in 1 studies

Other Studies

1 other study(ies) available for Rhynchophylline and Alzheimer-Disease

ArticleYear
Regioselective pyrrolizidine bis-spirooxindoles as efficient anti-amyloidogenic agents.
    European journal of medicinal chemistry, 2022, Oct-05, Volume: 240

    Here, we report a microwave-assisted, one-pot, three-component, 1,3-dipolar cycloaddition reaction to produce highly regioselective and stereoselective bis-spirooxindoles as potential inhibitors against amyloid-β fibrillation. Ease of synthesis, promising anti-amyloidogenic activity, low toxicity, and in vitro blood brain barrier permeability makes these compounds attractive therapeutic leads to treat Alzheimer's disease.

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Blood-Brain Barrier; Cycloaddition Reaction; Humans

2022